Medical Weight Loss for Whittier, California Residents
Whittier, California residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Important: Compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical. Eligibility and results vary.
Physician-supervised GLP-1 programs from $166/month, serving Whittier through telehealth from our Costa Mesa, California clinic. Doctor review $119. Bilingual support available.
Why Whittier Residents Choose New Hope Weight Loss
At New Hope Weight Loss, every case in Whittier is overseen by a named physician, Dr. Anjmun Sharma, MD. You are not handed off to a rotating panel of strangers or a faceless intake bot. Dr. Sharma reviews your history, signs off on your plan, and stays accountable for it. That single point of medical responsibility is rare in telehealth, and it is the reason so many people across California trust us to guide a serious decision about their health.
Whittier patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.
Living in Whittier, California means your weight-loss care comes to you online rather than the other way around, with Dr. Anjmun Sharma supervising each step from our Costa Mesa practice. We care for patients throughout Uptown Whittier and the greater eastern Los Angeles County area. Your plan is shaped around your own history, the medications you have tried, and the goals you bring, not a one-size template applied to every Whittier patient.
For patients in California, availability, timing. Any location-related charge require current confirmation. The compounded tirzepatide option is separate from Mounjaro and Zepbound. It is not FDA-approved or brand-identical, and results vary. Published reference pricing starts at $233 per month for Whittier patients and is billed apart from the $119 visit. California is our home state and our physical clinic sits in Costa Mesa, but we care for patients across the rest of the state by secure telehealth.
GLP-1 Weight Loss Programs Available
Begin your reset: semaglutide, from $166/mo
For context, STEP 1 reported an average 14.9% at 68 weeks for brand semaglutide. That result does not predict response to compounded semaglutide, which is not FDA-approved or brand-identical. Results vary, and the appropriate option depends on physician review, tolerability, access, and total cost.
Compare options with physician review
For context, SURMOUNT-1 reported an average 20.9% at 72 weeks for brand tirzepatide 15 mg. That result does not predict response to compounded tirzepatide, which is not FDA-approved or brand-identical. Results vary, and the appropriate option depends on physician review, tolerability, access, and total cost.
Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Whittier
The path from curious to treated is short, and it all runs through your screen. People in Whittier start by completing a health-and-weight intake quiz online. Dr. Anjmun Sharma reviews every answer and meets you over secure video, after intake review, to talk through whether a compounded GLP-1 like semaglutide or tirzepatide fits your goals and history. When she prescribes, medication fulfillment is considered only if a prescription is approved and the dispensing pharmacy confirms it can fulfill the prescription for the location where the patient will receive care; the pharmacy confirms packaging and shipping details before fulfillment. After that, you and Dr. Sharma stay connected through video follow-ups, so your progress is supported from any corner of California.
Frequently Asked Questions, Whittier
Does New Hope Weight Loss actually serve Whittier, or only Costa Mesa?
We serve both. Our single physical location sits in Costa Mesa, California, and we extend care to Whittier, California through telehealth. Residents across neighborhoods like Uptown Whittier and the greater eastern Los Angeles County area qualify the same way. Dr. Anjmun Sharma evaluates whether a compounded GLP-1 plan fits you during your initial video appointment.
Can the whole process be done remotely from Whittier?
Yes, it is fully remote. There is no in-person requirement for Whittier patients at any stage. You meet Dr. Sharma over video, complete intake online, and receive ongoing support by message. Approved prescriptions arrive at your door in insulated Packaging and shipping are confirmed before fulfillment only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient location.
How much will a Whittier patient pay?
Plan on $119 for the physician visit. Semaglutide runs from $166 monthly, with a $499 option for 90 days, and tirzepatide from $233 monthly. The medication cost is separate from the visit. HSA, FSA, Klarna, and Affirm are all welcome, and Whittier residents pay no added distance fee.
What areas of Whittier do you serve?
We serve patients from across Whittier by telehealth, including Uptown Whittier and the greater eastern Los Angeles County area.
What does treatment cost for Whittier patients?
Current published reference pricing is: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted. Any location-related charge for Whittier must be confirmed in writing.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Whittier, California by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.